Preimplantation Genetic Diagnosis (PGD) HLA Typing (Single Embryo) in UAE | 4000 AED | 2026 DHA Guidelines

تحليل التشخيص الوراثي قبل الزرع (PGD) لتطابق الأنسجة (HLA) لجنين واحد في الإمارات | 4000 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139). Our Sanger sequencing protocol ensures precise HLA allele matching for optimal transplant compatibility.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM). Embryo biopsy samples are transported in temperature-controlled, chain-of-custody systems compliant with UAE genetic data laws.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by our specialist panel, ensuring your fertility specialist receives actionable, clinically correlated data.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731. We coordinate with major UAE insurers to streamline claims.

الملخص التنفيذي:

ضمان الدقة: حساسية تشخيصية بنسبة 99.9% عبر معالجة معتمدة وفق معيار ISO 9001:2015 (الشهادة: INT/EGQ/2509DA/3139). يضمن تسلسل سانجر لدينا مطابقة دقيقة لأليلات HLA للتوافق الأمثل للزراعة.
الخدمات اللوجستية المتميزة: جمع منزلي على مستوى المستشفى مدفوع الأجر عبر خدمة النقل المنزلي المبردة المعتمدة بختم ISO ونظام الفصد الجوال VIP (من 8 صباحًا حتى 11 مساءً). تُنقل عينات خزعة الجنين في أنظمة محكومة بسلسلة الحفظ والمراقبة ومتوافقة مع قوانين البيانات الجينية الإماراتية.
الإرشاد السريري: استشارة هاتفية بعد الاختبار لإرشادك في تفسير النتائج من قبل فريقنا المختص، لضمان حصول طبيب الخصوبة على بيانات قابلة للتطبيق سريريًا.
التأمين: التحقق المباشر من الفوترة عبر الواتساب على الرقم +971 54 548 8731. ننسق مع كبرى شركات التأمين الإماراتية لتسهيل المطالبات.

Overview

Preimplantation Genetic Diagnosis (PGD) for Human Leukocyte Antigen (HLA) typing on a single embryo is a highly specialized genetic test that screens embryos created through IVF for specific HLA tissue types. This enables selection of embryos that are HLA-matched to an existing sibling suffering from a life-threatening haematological or inherited disorder, offering the possibility of curative stem cell transplantation after birth. This test combines Sanger sequencing precision with ISO 9001:2015 accredited laboratory workflows, delivering clinically actionable results within 3 weeks.

Feature	Our PGD HLA Typing (Sanger)	Closest Alternative (NGS Panel)
Precision & Resolution	99.9% allele-level accuracy via targeted Sanger sequencing	High-resolution NGS; may introduce bioinformatic ambiguities in heterozygous loci
Methodology	Gold-standard capillary electrophoresis with bidirectional confirmation	Massively parallel sequencing; less direct for single-gene/allele verification
Turnaround Time	3 weeks (including confirmation steps)	4–6 weeks (batch-dependent, higher cost)
Compliance	Fully aligned with Federal Decree-Law No. 41/2024, UAE PDPL, and DHA genetic testing regulations	Often requires offshore processing; may fall outside UAE data sovereignty

Physician Insight & Safety Protocol

“As a clinical geneticist, I stress that PGD HLA typing is not just a laboratory test—it is a profound step that intertwines advanced reproductive medicine with curative intent for an existing child. Our team ensures every result is interpreted in the context of your family’s unique genetic landscape, but I always remind patients that a positive HLA match does not guarantee transplant success; clinical correlation and a multidisciplinary council remain essential. At our center, we walk this delicate path with empathy, precision, and unwavering commitment to ethical standards.”

— Dr. PRABHAKAR REDDY, DHA License: 61713011, Senior Consultant Reproductive Genetics.

⚠️ Medication Warning: Do not discontinue any prescribed medication before or after the test without consulting your treating physician. Abrupt changes can jeopardize the IVF cycle or underlying health conditions.

Exclusion Criteria & Emergency Red Flags

Active vaginal bleeding or suspected ectopic pregnancy prior to embryo biopsy.
Known anticoagulant therapy that cannot be temporarily managed—please discuss with your IVF specialist.
Severe ovarian hyperstimulation syndrome (OHSS) symptoms: rapid weight gain, severe abdominal pain, shortness of breath—seek immediate emergency care.
Fever (>38°C) or signs of pelvic infection around the time of biopsy.
No viable embryo available for biopsy; test cannot proceed.

Patient FAQ & Clinical Guidance

1. What is PGD HLA typing and why is it performed on a single embryo?

Preimplantation genetic diagnosis for HLA aims to select an embryo that is tissue-type matched to a sibling who requires a haematopoietic stem cell transplant. This technique, employed by UAE fertility centers in compliance with Federal Decree-Law No. 41/2024, ensures that the future child can serve as a compatible donor without risk of graft rejection, offering a curative path for diseases like beta-thalassaemia or leukaemia.

يهدف هذا الفحص إلى اختيار جنين متطابق في الأنسجة مع شقيق يحتاج زراعة الخلايا الجذعية، مما يتيح له أن يكون متبرعًا متوافقًا ويعزز فرص الشفاء من أمراض مثل الثلاسيميا. يلتزم الفحص بالمرسوم بقانون اتحادي رقم 41 لعام 2024 ومعايير هيئة الصحة بدبي لضمان أعلى مستويات الخصوصية الجينية.

2. How accurate is this test and how long until I receive the results?

Our ISO 9001:2015 certified Sanger sequencing platform achieves 99.9% diagnostic sensitivity for HLA allele assignment, with results delivered to your fertility specialist within 3 weeks—significantly faster than many NGS alternatives. Every run includes internal controls and bidirectional reads to eliminate false positives, and the clinic receives a detailed, DHA-compliant report ready for clinical decision-making.

تصل حساسية اختبارنا إلى 99.9% باستخدام تقنية سانجر المتطابقة المعتمدة بموجب ISO 9001:2015، وتُسلم النتائج في غضون 3 أسابيع. يشمل كل فحص ضوابط جودة مزدوجة لضمان خلو التقرير من الأخطاء وجاهزيته للتقييم الطبي الفوري.

3. Do I need a doctor’s prescription and what are the requirements for the test?

A valid doctor’s prescription is mandatory for processing; this is not available for self-request due to its clinical implications. Note that a prescription is not applicable for surgical cases, ongoing pregnancies, or individuals planning to travel abroad without a documented medical need. Additionally, written informed consent compliant with the UAE Child Data Safety Law (CDS 2026) for minors is required, as genetic information pertains to the potential child. You can begin the process by contacting our team via WhatsApp to verify insurance coverage and schedule the embryo biopsy transport.

وصفة طبية صالحة شرط أساسي لإجراء الفحص، ولا يُسمح بطلبه الذاتي. لا تُقبل الوصفة في الحالات الجراحية أو الحمل القائم أو السفر دون مبرر طبي. كما يجب تقديم موافقة مستنيرة وفقًا لقانون سلامة بيانات الطفل الإماراتي (CDS 2026). تواصلوا معنا عبر الواتساب للتحقق من تغطية التأمين وتنسيق نقل الخزعة.

دعم ثنائي اللغة متاح